<DOC>
	<DOCNO>NCT00116181</DOCNO>
	<brief_summary>The investigator 's laboratory study skin disease know psoriasis . The purpose protocol study action effect Etanercept , psoriasis . This medication study extensively find effective safe treatment psoriasis . The eligible patient 10 % his/her body surface area involve psoriasis vulgaris . This trial phase III study help understand action drug etanercept , trade name Enbrel , adult patient moderate severe plaque psoriasis candidate internal medication .</brief_summary>
	<brief_title>Study Help Understand Action Drug Etanercept Adult Patient With Psoriasis</brief_title>
	<detailed_description>The eligible patient receive drug Etanercept ( Enbrel ) , self inject Etanercept twice week first 12 week . The patient teach self inject medication home see clinic weekly , first four week month . During second 12 week study , patient place one two group drug company participate . One group patient randomize either continue receive medication self inject week . A second group randomize receive medication continue follow examine monthly visit . The drug company randomization choice group , patient one two chance place one group . At clinic visit , patient expect physical exam skin exam do . At specific week , blood work drawn , clinical photography take skin biopsy do . Two type skin biopsy do local anesthesia administer . One punch biopsy small piece skin take , approximate size pencil eraser . The second type skin biopsy shave biopsy , postage size piece skin take .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Gender : Male Female Minimum Age : 18 Maximum Age : 70 Healthy Volunteers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>